How to Become an Authorised Cannabis Importer in the UK

Overview of the Dual Licensing Requirement

• Importers must obtain a Wholesale Dealer’s Authorisation from the MHRA for medicinal product aspects
• A Controlled Drug import licence from the Home Office is required for each consignment
• Both licences are necessary; holding one without the other is insufficient to operate legally
• Additional GPhC registration may be required if the importer also dispenses to patients

Becoming an authorised medical cannabis importer in the United Kingdom requires engagement with two separate regulatory bodies for two separate licence types. The MHRA governs the medicinal product aspects of the import operation; the Home Office controls the controlled drug aspects. This dual licensing requirement is one of the defining characteristics of the UK import pathway and shapes the compliance infrastructure that legitimate importers must build.

Step-by-Step: Obtaining a Wholesale Dealer’s Authorisation

• Identify and appoint a Responsible Person with an appropriate pharmaceutical background
• Establish GDP-compliant storage premises and document their compliance in detail
• Complete the MHRA WDA application form with supporting documentation
• Prepare for and pass the MHRA pre-authorisation GDP inspection

The Wholesale Dealer’s Authorisation application process begins long before the application form is submitted. Building the infrastructure that will satisfy the MHRA’s GDP inspection — compliant premises, appropriate personnel, documented quality systems — is the foundation of the process. Applications submitted without this infrastructure in place will not succeed. The WDA is a gate through which only operationally ready applicants can pass.

Home Office Import Licensing Process

• Controlled drug import licence applications are submitted to the Home Office Drugs Licensing unit
• Each application specifies the product, quantity, supplier, and intended timeframe
• The exporting country must confirm it will authorise the export before the UK import licence is granted
• Licence issuance timelines vary; applicants should plan for at least four to six weeks per consignment

The Home Office import licensing process operates on a per-consignment basis, meaning that each delivery of cannabis products requires a separate licence. This creates an ongoing administrative requirement that must be managed as part of operational planning. Importers should establish relationships with the Home Office Drugs Licensing unit, maintain accurate records of all applications, and factor licence lead times into commercial planning and supply agreements with overseas producers.

Building a Compliance Function for Long-Term Operations

• Designate a Responsible Person and build a quality assurance function before going live
• Implement a Quality Management System covering all aspects of the import operation
• Establish supplier qualification procedures for all EU-GMP certified sources
• Conduct regular internal audits and be prepared for unannounced MHRA inspections

The compliance requirements for an authorised medical cannabis importer do not diminish after licences are obtained — they represent an ongoing operational commitment. Regulators expect continuous GDP compliance, not just compliance at the point of authorisation. Building a robust compliance function, with clear responsibilities, documented procedures, and regular review processes, is the foundation of a sustainable import business. Companies that treat compliance as a permanent operational priority — rather than a one-time hurdle — build the regulatory goodwill that supports long-term commercial success.